Trials / Completed
CompletedNCT01681316
Danhong Injection in the Treatment of Chronic Stable Angina
A Randomized, Multi-center, Double-blind, Placebo-controlled Trial of Danhong Injection in the Treatment of Chronic Stable Angina
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 920 (actual)
- Sponsor
- China Academy of Chinese Medical Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the effect of Danhong Injection on the relief of angina with the use of the Seattle Angina Questionnaire among patients with stable angina patients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Danhong injection | A kind of injection made from two kind of Chinese herbs: salvia miltiorrhiza and safflower |
| OTHER | Standard medical care | Standard medical care is in accordance with China Guideline for the diagnosis and treatment of Chronic Stable Angina (2007). |
| DRUG | Placebo | 0.9% saline added into 250ml 0.9% saline by an independent research nurse, sealed with brown bag in order to make the investigators and patients blinded, using brown infusion tube for infusion. |
Timeline
- Start date
- 2012-12-01
- Primary completion
- 2016-10-01
- Completion
- 2016-10-01
- First posted
- 2012-09-07
- Last updated
- 2016-10-12
Locations
31 sites across 1 country: China
Source: ClinicalTrials.gov record NCT01681316. Inclusion in this directory is not an endorsement.